Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.58 |
| ▸ | CYSLTR1 | Q9Y271 | 8/20 | 0.58 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.57 |
| ▸ | CYSLTR2 | Q9NS75 | 5/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9407515 | 0.85 | GPBAR1 (0.65) | FFAR1AKR1B1CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL1419872 | 0.81 | FFAR1 (0.77) | ALOX5FFAR1AKR1B1CYSLTR1GPBAR1 | |
| SCHEMBL9407580 | 0.78 | CYSLTR1 (0.69) | CYSLTR1GPBAR1CYSLTR2 | |
| SCHEMBL9407541 | 0.78 | ALOX5 (0.55) | ALOX5FFAR1AKR1B1CYSLTR1GPBAR1 | |
| SCHEMBL8800199 | 0.78 | ALOX5 (0.72) | ALOX5FFAR1AKR1B1CYSLTR1GPBAR1 | |
| SCHEMBL13772730 | 0.78 | GPBAR1 (0.70) | ALOX5FFAR1AKR1B1CYSLTR1GPBAR1 | |
| SCHEMBL1419915 | 0.77 | ALOX5 (0.72) | ALOX5FFAR1AKR1B1CYSLTR1GPBAR1 | |
| SCHEMBL8902567 | 0.77 | ALOX5 (0.72) | ALOX5FFAR1AKR1B1CYSLTR1GPBAR1 | |
| SCHEMBL13772715 | 0.75 | GPBAR1 (0.74) | ALOX5FFAR1AKR1B1CYSLTR1GPBAR1 | |
| Acetic Acid SCHEMBL9525259 | 0.75 | GPBAR1 (0.67) | ALOX5FFAR1AKR1B1CYSLTR1GPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0610943-A1 | Pyridinium derivatives useful as PAF antagonists | J. URIACH & CIA. S.A. (ES) | 1994-08-17 | — | — | EP | disclosed |